JB Pharma publishes sustainability report for FY 2022-23
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
The state-of-the-art digital PETCT imaging system, highlights a significant advancement in the fight against cancer and detects other lesions offering patient centric services
The generous donation includes multiple medical equipments
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
Sarah currently serves as the Chief Financial Officer and Principal Accounting Officer for Criteo S.A.
This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US
The companies will spread the adoption of the latest HOS and Mass Spec technologies to help scientists improve the safety, stability, and effectiveness of biotherapeutics
This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities in the South African market
Subscribe To Our Newsletter & Stay Updated